Bone mineral density during total contact cast immobilization for a patient with neuropathic (Charcot) arthropathy

Physical Therapy

Volumn 85, Issue 3, 2005, Pages 249-256

  Hastings, Mary K ^a   Sinacore, David R ^a   Fielder, Faye A ^b   Johnson, Jeffrey E ^b  

^a WASHINGTON UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Arthropathy; Diabetes mellitus; Foot diseases; Fractures, neurogenic

Indexed keywords

ADULT; ARTICLE; BONE DENSITY; BRACE; CALCANEUS; CASE REPORT; DIABETES MELLITUS; DISEASE COURSE; FEMALE; FOOT DISEASE; FRACTURE; HUMAN; IMMOBILIZATION; KIDNEY FAILURE; NEUROPATHIC JOINT DISEASE; OSTEOLYSIS; PLASTER CAST; RECURRENT DISEASE; SHOE; ULTRASOUND; WEIGHT BEARING;

EID: 14744290258     PISSN: 00319023     EISSN: None     Source Type: Journal    
DOI: 10.1093/ptj/85.3.249     Document Type: Article

References (40)

1. Armstrong DG, Lavery LA. Acute Charcot's arthropathy of the foot and ankle. Phys Ther. 1998;78:74-80.
2. Sinacore DR, Withrington NC. Recognition and management of acute neuropathic (Charcot) arthropathies of the foot and ankle. J Orthop Sports Phys Ther. 1999;29:736-746.
3. Frykberg RG, Mendeszoon E. Management of the diabetic Charcot foot. Diabetes Metab Res Rev. 2000;16(suppl 1):S59-S65.
4. Sinacore DR. Acute Charcot arthropathy in patients with diabetes mellitus: healing times by foot location. J Diabetes Complications. 1998; 12:287-293.
5. Teitelbaum SL. Bone resorption by osteoclasts. Science. 2000;289: 1504-1508.
6. Gough A, Abraha H, Li F, et al. Measurement of markers of osteoclast and osteoblast activity in patients with acute and chronic diabetic Charcot neuroarthropathy. Diabet Med. 1997;14:527-531.
7. Stevens MJ, Edmonds ME, Foster AV, Watkins PJ. Selective neuropathy and preserved vascular responses in the diabetic Charcot foot. Diabetologia. 1992;35:148-154.
8. Edmonds ME, Clarke MB, Newton S, et al. Increased uptake of bone radiopharmaceutical in diabetic neuropathy. Q J Med. 1985;57: 843-855.
9. Rajbhandari SM, Jenkins RC, Davies C, Tesfaye S. Charcot neuroarthropathy in diabetes mellitus. Diabetologia. 2002;45:1085-1096.
10. Young MJ, Marshall A, Adams JE, et al. Osteopenia, neurological dysfunction, and the development of Charcot neuroarthropathy. Diabetes Care. 1995;18:34-38.
11. Sinacore DR, Roger RC, Johnson JE. Inflammatory bone loss in neuropathic (Charcot) arthropathies of the foot. J Orthop Sports Phys Ther. 2003;33:A-13.
12. McGill M, Molyneaux L, Bolton T, et al. Response of Charcot's arthropathy to contact casting: assessment by quantitative techniques. Diabetologia. 2000;43:481-484.
13. Holick MF. Perspective on the impact of weightlessness on calcium and bone metabolism. Bone. 1998;22:105S-I11S.
14. Mueller MJ, Diamond JE, Delitto A, Sinacore DR. Insensitivity, limited joint mobility, and plantar ulcers in patients with diabetes mellitus. Phys Ther. 1989;69:453-459.
15. Diamond JE, Mueller MJ, Delitto A, Sinacore DR. Reliability of a diabetic foot evaluation. Phys Ther. 1989;69:797-802.
16. Ewing DJ, Martyn CN, Young RJ, Clarke BF. The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care. 1985;8:491-498.
17. Sinacore DR, Roger RC, Villareal DTSMJ. Precision of serial quantitative ultrasonometry measures of the calcaneus. Abstract presented at: Combined Sections Meeting of the American Physical Therapy Association; February 5, 2003; Tampa, Fla.
18. Greenspan SL, Bouxsein ML, Melton ME, et al. Precision and discriminatory ability of calcaneal bone assessment technologies. J Bone Miner Res. 1997;12:1303-1313.
19. Greenspan SL, Cheng S, Miller PD, et al. Clinical performance of a highly portable, scanning calcaneal ultrasonometer. Osteoporos Int. 2001;12:391-398.
20. Sahara Clinical Bone Sonometer: Clinical User's Guide. Bedford, Mass: Hologic Inc; 1998.
21. Armstrong DG, Lavery LA. Monitoring healing of acute Charcot's arthropathy with infrared dermal thermometry. J Rehabil Res Dev. 1997;34:317-321.
22. Exergen User's Manual and Reference. Watertown, Mass: Exergen Corp; 2002.
23. Waylett J, Seibly D. A study of the accuracy of a commercially available volumeter. J Hand Ther. 1991;4:10-13.
24. Petersen EJ, Irish SM, Lyons CL, et al. Reliability of water volumetry and the figure of eight method on subjects with ankle joint swelling. J Orthop Sports Phys Ther. 1999;29:609-615.
25. King TI Jr. The effect of water temperature on hand volume during volumetric measurement using the water displacement method. J Hand Ther. 1993;6:202-204.
26. Sinacore DR, Mueller MJ. Total contact casting for neuropathic ulcers. In: Levin ME, O'Neal LW, Bowker JH, eds. The Diabetic Fool. St Louis, Mo: Mosby-Yearbook; 1993:283-304.
27. Morgan JM, Biehl WC III, Wagner FW Jr. Management of neuropathic arthropathy with the Charcot Restraint Orthotic Walker. Clin Orthop. November 1993(296):58-63.
28. Carlson JM, Hollerbach F, Day B. A calf corset weightbearing ankle-foot orthosis design. Journal of Prosthetics & Orthotics. 1992;4: 41-44.
29. Genant HK, Cooper C, Poor G, et al. Interim report and recommendations of the World Health Organization Task-Force for Osteoporosis. Osteoporos Int. 1999;10:259-264.
30. Armour KJ, Armour KE, van't Hof RJ, et al. Activation of the inducible nitric oxide synthase pathway contributes to inflammation-induced osteoporosis by suppressing bone formation and causing osteoblast apoptosis. Arthritis Rheum. 2001;44:2790-2796.
31. Rix M, Andreassen H, Eskildsen P. Impact of peripheral neuropathy on bone density in patients with type 1 diabetes. Diabetes Care. 1999; 22:827-831.
32. Tuominen JT, Impivaara O, Puukka P, Ronnemaa T. Bone mineral density in patients with type 1 and type 2 diabetes. Diabetes Care. 1999;22:1196-1200.
33. Forst T, Pfutzner A, Kann P, et al. Peripheral osteopenia in adult patients with insulin-dependent diabetes mellitus. Diabet Med. 1995;12: 874-879.
34. Kayath MJ, Dib SA, Vieiaa JG. Prevalence and magnitude of osteopenia associated with insulin-dependent diabetes mellitus. J Diabetes Complications. 1994;8:97-104.
35. Cundy TF, Edmonds ME, Watkins PJ. Osteopenia and metatarsal fractures in diabetic neuropathy. Diabet Med. 1985;2:461-464.
36. Taal MW, Masud T, Green D, Cassidy MJ. Risk factors for reduced bone density in haemodialysis patients. Nephrol Dial Transplant. 1999; 14:1922-1928.
37. Arici M, Erturk H, Altun B, et al. Bone mineral density in haemodialysis patients: a comparative study of dual-energy X-ray absorptiometry and quantitative ultrasound. Nephrol Dial Transplant. 2000;15: 1847-1851.
38. Peretz A, Penaloza A, Mesquita M, et al. Quantitative ultrasound and dual X-ray absorptiometry measurements of the calcaneus in patients on maintenance hemodialysis. Bone. 2000;27:287-292.
39. Armstrong DG, Lavery LA, Liswood PJ, et al. Infrared dermal thermometry for the high-risk diabetic foot. Phys Ther. 1997;77: 169-175.
40. McCrory JL, Morag E, Norkitis AJ, et al. Healing of Charcot fractures: skin temperature and radiographic correlates. Foot. 1998;8: 158-165.